首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
【24h】

Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.

机译:在研究宫颈癌进展过程中的多种人乳头瘤病毒基因型感染中,了解宫颈癌的早期终点和决定因素。

获取原文
获取原文并翻译 | 示例
           

摘要

Determining the causal attribution of human papillomavirus (HPV) genotypes to cervical disease is important to estimate the effect of HPV vaccination and to establish a type spectrum for HPV-based screening. We analyzed the prevalence of HPV infections and their attribution to cervical disease in a population of 1,670 women referred to colposcopy for abnormal cytology at the University of Oklahoma. HPV genotyping was performed from cytology specimens using the Linear Array assay that detects 37 HPV genotypes. We used different methods of type attribution to revised cervical disease categories. We found very high prevalence of multiple HPV infections with up to 14 genotypes detected in single specimens. In all disease categories except for cancers, there was a significant trend of having more infections at a younger age. We did not see type interactions in multiple genotype infections. HPV16 was the most frequent genotype at all disease categories. Based on different attribution strategies, the attribution of vaccine genotypes (6, 11, 16, 18) ranged from 50.5 to 67.3% in cancers (n = 107), from 25.6 to 74.8% in CIN3 (n = 305), from 15.2 to 52.2% in CIN2 (n = 427), and from 6.6 to 26.0% in
机译:确定人乳头瘤病毒(HPV)基因型与宫颈疾病的因果关系对于评估HPV疫苗接种的效果并为基于HPV的筛查建立类型谱非常重要。我们分析了俄克拉荷马大学(University of Oklahoma)因阴道镜检查异常而接受阴道镜检查的1,670名女性人群中HPV感染的流行及其对宫颈疾病的归因。使用检测37种HPV基因型的线性阵列分析法从细胞学标本中进行HPV基因分型。我们对修订的宫颈疾病类别使用了不同的类型归因方法。我们发现多种HPV感染的患病率很高,单个样本中检测到多达14种基因型。在除癌症以外的所有疾病类别中,都有一个明显的趋势,即在年轻时感染更多。我们没有在多种基因型感染中看到类型相互作用。 HPV16是所有疾病类别中最常见的基因型。根据不同的归因策略,癌症(n = 107)的疫苗基因型(6、11、16、18)的归因范围为50.5%至67.3%,CIN3(n = 305)的疫苗基因型范围为25.6至74.8%,从15.2至CIN2中为52.2%(n = 427),

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号